Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kejin Wu

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
International Journal of General Medicine|August 26, 2021
<i>HOTAIR</i> Facilitates Endocrine Resistance in Breast Cancer Through <i>ESR1</i>/<i>miR-130b-3p</i> Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA NetworkMingdi Zhang, Kejin Wu, Peng Zhang, et al.
Breast Cancer Research and Treatment|April 26, 2019
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysisMaoli Wang, Hongliang Chen, Kejin Wu, et al.
Cancer Medicine|October 27, 2017
Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysisHongliang Chen, Kejin Wu, Maoli Wang, et al.
Annals of Surgical Oncology|November 21, 2018
The Prognostic Significance of the Oncotype DX Recurrence Score in T<sub>1-2</sub>N<sub>1</sub>M<sub>0</sub> Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th EditionMaoli Wang, Kejin Wu, Peng Zhang, et al.
Clinical Breast Cancer|December 1, 2018
Immediate Breast Reconstruction in De Novo Metastatic Breast Cancer: An Analysis of 563 Cases Based on the SEER DatabaseHongliang Chen, Mingdi Zhang, Maoli Wang, et al.
Breast (Edinburgh, Scotland)|November 4, 2017
Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 databaseMaoli Wang, Hongliang Chen, Kejin Wu, et al.
Scientific Reports|April 22, 2024
Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstructionJingjing Yuan, Meilin Zhang, Maoli Wang, et al.
Breast Care (Basel, Switzerland)|June 15, 2017
Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-AnalysisFang Bai, Yunshu Lu, Kejin Wu, et al.
Medical Oncology (Northwood, London, England)|May 7, 2014
Levels of lymphocyte subsets in peripheral blood prior treatment are associated with aggressive breast cancer phenotypes or subtypesYijun Jia, Lei Xu, Qing Lin, et al.
Chinese Medical Journal|June 17, 2014
Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virusMingzhe Weng, Mingdi Zhang, Yiyu Qin, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
International Journal of General Medicine|August 26, 2021
<i>HOTAIR</i> Facilitates Endocrine Resistance in Breast Cancer Through <i>ESR1</i>/<i>miR-130b-3p</i> Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA NetworkMingdi Zhang, Kejin Wu, Peng Zhang, et al.
Breast Cancer Research and Treatment|April 26, 2019
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysisMaoli Wang, Hongliang Chen, Kejin Wu, et al.
Cancer Medicine|October 27, 2017
Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysisHongliang Chen, Kejin Wu, Maoli Wang, et al.
Annals of Surgical Oncology|November 21, 2018
The Prognostic Significance of the Oncotype DX Recurrence Score in T<sub>1-2</sub>N<sub>1</sub>M<sub>0</sub> Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th EditionMaoli Wang, Kejin Wu, Peng Zhang, et al.
Clinical Breast Cancer|December 1, 2018
Immediate Breast Reconstruction in De Novo Metastatic Breast Cancer: An Analysis of 563 Cases Based on the SEER DatabaseHongliang Chen, Mingdi Zhang, Maoli Wang, et al.
Breast (Edinburgh, Scotland)|November 4, 2017
Evaluation of the prognostic stage in the 8th edition of the American Joint Committee on Cancer in locally advanced breast cancer: An analysis based on SEER 18 databaseMaoli Wang, Hongliang Chen, Kejin Wu, et al.
Scientific Reports|April 22, 2024
Neoadjuvant radiochemotherapy is safe and feasible for breast conserving surgery or immediate reconstructionJingjing Yuan, Meilin Zhang, Maoli Wang, et al.
Breast Care (Basel, Switzerland)|June 15, 2017
Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-AnalysisFang Bai, Yunshu Lu, Kejin Wu, et al.
Medical Oncology (Northwood, London, England)|May 7, 2014
Levels of lymphocyte subsets in peripheral blood prior treatment are associated with aggressive breast cancer phenotypes or subtypesYijun Jia, Lei Xu, Qing Lin, et al.
Chinese Medical Journal|June 17, 2014
Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virusMingzhe Weng, Mingdi Zhang, Yiyu Qin, et al.
Pageof 5